PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
John Samuel |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Alan Miller |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Antony Odell |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Jonathan Glenn |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Paul Devlin |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Steven Couldwell |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Shervanthi Homer Vanniasinkam |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Tissue Regenix Group plc |
||||
b) |
LEI |
213800PNOD5UHQUFJI36 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Subscription for ordinary shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A
|
||||
e) |
Date of the transaction |
9 August 2017 |
||||
f) |
Place of the transaction |
Outside a trading venue |